DCF — SHELBY BAPTIST MEDICAL CENTER
Enterprise Value: $-50.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-50.4M
Enterprise Value
$-20.5M
PV of Cash Flows
$-30.0M
PV of Terminal Value
$-48.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $165.9M | $-0.7M | -0.0% | $-7.7M | $-7.0M |
| Year 2 | $170.9M | $1.0M | 1.0% | $-6.2M | $-5.1M |
| Year 3 | $176.0M | $2.8M | 2.0% | $-4.6M | $-3.5M |
| Year 4 | $181.3M | $3.8M | 2.0% | $-3.9M | $-2.7M |
| Year 5 | $186.7M | $4.4M | 2.0% | $-3.5M | $-2.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-50.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$161.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.009077422446200373
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5